A study reported that the testosterone levels decreased in 60–64% of rectal cancer patients, LH increased significantly in 80–91% of patients, FSH increased significantly in 95% of patients after chemotherapy, and the FSH values further increased in all patients during the one-year follow-up [11]. The gene discussed is PLOD1; the disease is rectal cancer.